International Scholarly Research Notices

Clinical Study

Endometrial Cancer Patients: A Cohort Previous to Changes in Tumour Behaviour and Treatment Strategies

Table 1

5-year survival rates of š‘› = 1 9 1 patients with endometrial carcinoma diagnosed between 2002 and 2009. Subdivided into histological tumour type, FIGO stage and histological tumour grade.
OSaDSSbDFSc
Histology
ā€ƒEndometrioid73.5%87.7%89.2%
ā€ƒPapillary serous59.6%59.6%68.6%
ā€ƒClear celld40.0%80.0%60.0%
FIGO
ā€ƒStage I77.5%92.6%91.0%
ā€ƒStage II72.5%80.0%75.0%
ā€ƒStage III51.7%51.7%59.6%
ā€ƒStage IV25.0%25.0%ā€”
Tumour grade (within FIGO stage I endometrioid)
ā€ƒGrade 190.7%96.0%92.4%
ā€ƒGrade 274.5%93.1%90.7%
ā€ƒGrade 359.8%84.1%88.2%
a: 5-year overall survival.
b: 5-year disease-specific survival.
c: 5-year disease-free survival.
d: maximum follow-up: 46 months.